Please login to the form below

Not currently logged in
Email:
Password:

Celerion appoints chief medical officer

Dr Marc Hoffman brings experience from Patient IP and Theorem Clinical Research

Celerion Dr Marc HoffmanClinical research and pharmacology service provider Celerion has appointed Dr Marc Hoffman as chief medical officer.

Dr Hoffman joins Celerion from Patient Identification Platform, where he also served as chief medical officer, overseeing the firm's platform and programmes.

He brings further experience from Theorem Clinical Research, where he was chief medical officer, senior vice president and general manager.

Previously, Dr Hoffman served as vice president of medical and scientific affairs at Covance and vice president of global medical affairs and product safety at Hospira.

He also brings experience as vice president for global regulatory affairs and medical vigilance for Baxter's operations in Asia and the Americas.

Dr Susan Thornton, president and chief executive officer of Celerion, said: “We are pleased to have Marc join our executive leadership team during this exciting period of growth in our company.

“His depth of experience in managing all aspects of global drug development in multiple therapeutic areas will not only make him a valuable asset for our organization but also for our clients.”

27th February 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...

Latest intelligence

Emotion-driven clinical trial marketing: A missed opportunity?
Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...

Infographics